Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Optimising the benefits of oral anticoagulants for atrial fibrillation
+Practice
In print
Heartbeat
Optimising the benefits of oral anticoagulants for atrial fibrillation
Wednesday 7 June 2023, 12:25 AM

[Image: Supplied]
Oral anticoagulation reduces the rate of thromboembolism in patients with atrial fibrillation. Here, consultant cardiologist Chris Ellis reviews the importance of regular follow-up
This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.25 credits for continuing professional development purposes (1, Educate small, BACK panel - grey
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139–51.
2. Harper P, Chang A, Stephens M. The changing use of anticoagulants in New Zealand. NZ Med J 2022;135(1554):35–43.